Statin Use not Linked with Risk of Dementia in FH Patients: JAMAÂ MD Bureau25 April 2022 4:45 AM GMTDementia is one of the major causes of disability worldwide, affecting approximately 50 million people, with nearly 10 million new cases yearly....
Early treatment with statin reduces CV morbidity in Familial hypercholesterolemia, finds study Dr Sravan Kumar22 March 2022 3:30 AM GMTFamilial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevated serum low-density lipoprotein cholesterol (LDL-C) from...
Atherosclerosis may be delayed by early treatment in familial hypercholesterolemia: Study Medha Baranwal19 March 2022 3:30 AM GMTAmsterdam: Early initiation of lipid-lowering treatment and achieving treatment targets in patients with familial hypercholesterolemia (FH) may reduce...
Mumbai hospital performs coronary angioplasty on a 10-year old with a rare lipid disorder. dr. Abhimanyu Uppal23 Jun 2021 5:15 AM GMTMumbai: Familial hypercholesterolaemia (FH) is a primary genetic dyslipidemia characterized by elevation in serum low-density lipoprotein cholesterol...
Mediterranean diet may lower CVD risk in familial hypercholesterolemia patients: Study Medha Baranwal22 April 2021 5:04 PM GMTBrazil: Higher adherence to Mediterranean diet may improve lipid levels and inflammation in familial hypercholesterolemia (FH) patients, finds a...
Achilles Tendon Softness may help detect Familial hypercholesterolemia Dr Kartikeya Kohli2 April 2021 6:15 AM GMTFamilial hypercholesterolemia (FH) is an autosomal dominantly inherited disease characterized by markedly increased serum low-density...
Evinacumab gets FDA nod for treatment of rare homozygous FH in children Medha Baranwal12 Feb 2021 2:00 PM GMTUSA: The U.S. Food and Drug Administration (FDA) has given its approval to Regeneron's evinacumab (Evkeeza) as an adjunct to other low-density...
Pushing limits in dyslipidemia management: Novel drug Evinacumab gives promising results dr. Abhimanyu Uppal21 Dec 2020 12:07 PM GMTA new drug target is emerging for the treatment of patients in whom the LDL cholesterol level remains too high despite treatment with existing...
Evinacumab cuts LDL cholesterol by half in high risk patients: NEJM study Dr. Kamal Kant Kohli16 Nov 2020 5:30 AM GMTResearchers at Icahn School of Medicine of Mount Sinai have found in phase 2 study that the investigational drug evinacumab reduced low-density...
Restrict carbohydrate rather than saturated fat to manage high cholesterol: Study Hina Zahid7 July 2020 8:00 AM GMTTAMPA .- Researchers have found that a low carbohydrate diet (LCD) may effectively manage Familial hypercholesterolaemia rather than restricting...
Evinacumab cuts LDL cholesterol by half in familial hypercholesterolemia Dr. Kamal Kant Kohli3 April 2020 12:15 PM GMTMonoclonal antibody, Evinacumab effective for the full spectrum of homozygous familial hypercholesterolemia
